A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Ditching Invading DNA: Bacteria and archaea protect themselves from invasive foreign nucleic acids through an RNA-mediated adaptive immune system called CRISPR (clustered regularly interspaced short palindromic repeats)/CRISPR-associated (Cas). Jinek et al. (p. 816 , published online 28 June; see the Perspective by Brouns ) found that for the type II CRISPR/Cas system, the CRISPR RNA (crRNA) as well as the trans-activating crRNA—which is known to be involved in the pre-crRNA processing—were both required to direct the Cas9 endonuclease to cleave the invading target DNA. Furthermore, engineered RNA molecules were able to program the Cas9 endonuclease to cleave specific DNA sequences to generate double-stranded DNA breaks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To realize this promise, the development of CRISPR-Cas9 for genome editing offers a simpler technology that has been adopted widely due to the ease of programming its DNA binding and modifying capabilities.”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recombinant expression and purification of EvoCas9–1 paired with chemically synthesized Evo-generated single guide RNA (sgRNA) exhibited comparable in vitro cleavage activity to SpCas9 paired with the canonical SpCas9 sgRNA”
From Sequence modeling and design from molecular to genome scale with Evo (2024) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cas9 can create DNA cleavage at desired genomic positions that are guided by precise base pairing between sgRNA and DNA, adjacent to a protospacer-adjacent motif (PAM) (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Jinek et al., 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR/Cas9 is a class of ribonucleoprotein complexes formed by a Cas9 protein and a single guide RNA (sgRNA) (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Jinek et al., 2012
Experimental — accuracy not yet measured
31 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
Self-citationSmall CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P. L., Dickman, M. J., Makarova, K. S., Koonin, E. V., & van der Oost, J. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,460
Evolution and classification of the CRISPR–Cas systems
Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2577 · Cited by 2,331
Self-citationThe CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Garneau, J. E., Dupuis, M.-È., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadán, A. H., & Moineau, S. (2010) · Nature · doi:10.1038/nature09523 · Cited by 2,328
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
A TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098
Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
Christian, M., Cermak, T., Doyle, E. L., Schmidt, C., Zhang, F., Hummel, A., Bogdanove, A. J., & Voytas, D. F. (2010) · Genetics · doi:10.1534/genetics.110.120717 · Cited by 1,869
Cited by
Items 1,101–1,200 of 1,285
A Defined Zebrafish Line for High-Throughput Genetics and Genomics: NHGRI-1
LaFave, M. C., Varshney, G. K., Vemulapalli, M., Mullikin, J. C., & Burgess, S. M. (2014) · Genetics · doi:10.1534/genetics.114.166769 · Cited by 101
“CRISPRs in particular provide an efficient, easy, and inexpensive means of manipulating and interrogating the genome (Jinek et al. 2012; Cong et al. 2013; Mali et al. 2013).”
BackgroundTissue-restricted genome editing in vivo specified by microRNA-repressible anti-CRISPR proteins
Lee, J., Mou, H., Ibraheim, R., Liang, S.-Q., Liu, P., Xue, W., & Sontheimer, E. J. (2019) · RNA · doi:10.1261/rna.071704.119 · Cited by 100
CRISPR-Cas Biology and Its Application to Infectious Diseases
Strich, J. R., & Chertow, D. S. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01307-18 · Cited by 100
Gasparis, S., Kała, M., Przyborowski, M., Łyżnik, L. A., Orczyk, W., & Nadolska-Orczyk, A. (2018) · Plant Methods · doi:10.1186/s13007-018-0382-8 · Cited by 98
Targeting mutant KRAS with CRISPR-Cas9 controls tumor growth
Kim, W., Lee, S., Kim, H. S., Song, M., Cha, Y. H., Kim, Y.-H., Shin, J., Lee, E.-S., Joo, Y., Song, J. J., et al. (2018) · Genome Research · doi:10.1101/gr.223891.117 · Cited by 97
Xu, L., Zhao, L., Gao, Y., Xu, J., & Han, R. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1048 · Cited by 91
“The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Type II system is a bacterial immune system (1) which has gained an influx of scientific interest as a highly efficient molecular scissors to edit the cellular genome (2,3).”
BackgroundTargeted Heritable Mutation and Gene Conversion by Cas9-CRISPR in Caenorhabditis elegans
Katic, I., & Großhans, H. (2013) · Genetics · doi:10.1534/genetics.113.155754 · Cited by 95
Genome-wide compendium and functional assessment of in vivo heart enhancers
Dickel, D. E., Barozzi, I., Zhu, Y., Fukuda-Yuzawa, Y., Osterwalder, M., Mannion, B. J., May, D., Spurrell, C. H., Plajzer-Frick, I., Pickle, C. S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12923 · Cited by 93
Biased and unbiased methods for the detection of off-target cleavage by CRISPR/Cas9: An overview
Martin, F., Sánchez-Hernández, S., Gutiérrez-Guerrero, A., Pinedo-Gomez, J., & Benabdellah, K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091507 · Cited by 92
“The CRISPR/Cas9 system derived from bacterial adaptive immune systems [1–3] is one of the most powerful genome editing technology [4,5].”
BackgroundAdvances in targeted degradation of endogenous proteins
Röth, S., Fulcher, L. J., & Sapkota, G. P. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03112-6 · Cited by 92
Transcriptional regulation with CRISPR-Cas9: principles, advances, and applications
Didovyk, A., Borek, B., Tsimring, L., & Hasty, J. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.06.003 · Cited by 90
“Despite this, a few mismatches between guide sequence and target DNA can be tolerated [5 ,7,8 ,9], more so within the 5’ proximal position of the guide sequence.”
Horii, T., Tamura, D., Morita, S., Kimura, M., & Hatada, I. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141019774 · Cited by 90
Gaj, T., Staahl, B. T., Rodrigues, G. M. C., Limsirichai, P., Ekman, F. K., Doudna, J. A., & Schaffer, D. V. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx154 · Cited by 89
“The Cas9 protein from Streptococcus pyogenes (SpCas9) was expressed from pMJ915 (Addgene #69090) in Escherichia coli Rosetta 2 cells (EMD Millipore) and purified as previously described (1).”
BackgroundMethodSelf-citationCRISPR Approaches to Small Molecule Target Identification
Jost, M., & Weissman, J. S. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00965 · Cited by 88
The Developmental Genetics of Vertebrate Color Pattern Formation
Irion, U., Singh, A. P., & Nüsslein-Volhard, C. (2016) · Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2015.12.012 · Cited by 88
“…technologies and the novel possibilities of genome editing with the CRISPR/Cas9 system (Hwang et al., 2013; Irion, Krauss, & NüssleinVolhard, 2014; Jinek et al., 2012), allow for the first time to easily expand from model organisms into other species and directly test the function of genes by…”
Port, F., Muschalik, N., & Bullock, S. L. (2015) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.115.019083 · Cited by 87
Exosome/Liposome-like Nanoparticles: New Carriers for CRISPR Genome Editing in Plants
Alghuthaymi, M. A., Ahmad, A., Khan, Z., Khan, S. H., Ahmed, F. K., Faiz, S., Nepovimova, E., Kuča, K., & Abd-Elsalam, K. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147456 · Cited by 83
“The latest ground-breaking technology involving CRISPR/Cas9 is basically an adaptive immune system in type II prokaryotes that protects them against invading organisms during phage infection by spacer acquisition, biogenesis, and target degradation [92].”
BackgroundOne-step generation of myostatin gene knockout sheep via the CRISPR/Cas9 system
(2014) · Frontiers of Agricultural Science and Engineering · doi:10.15302/j-fase-2014007 · Cited by 86
“However, a comparable level of gene targeting can be mediated by a chimeric single-guide RNAs (sgRNAs), which results from the fusion of a crRNA and a tracrRNA, and this system is easier to operate both in vivo and in vitro [4].”
BackgroundGene silencing with CRISPRi in bacteria and optimization of dCas9 expression levels
Depardieu, F., & Bikard, D. (2020) · Methods · doi:10.1016/j.ymeth.2019.07.024 · Cited by 86
Advanced domestication: harnessing the precision of gene editing in crop breeding
Lyzenga, W. J., Pozniak, C. J., & Kagale, S. (2021) · Plant Biotechnology Journal · doi:10.1111/pbi.13576 · Cited by 85
Cas9 off-target binding to the promoter of bacterial genes leads to silencing and toxicity
Rostain, W., Grebert, T., Vyhovskyi, D., Pizarro, P. T., Tshinsele-Van Bellingen, G., Cui, L., & Bikard, D. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad170 · Cited by 85
Accurate analysis of genuine CRISPR editing events with ampliCan
Labun, K., Guo, X., Chavez, A., Church, G., Gagnon, J. A., & Valen, E. (2019) · Genome Research · doi:10.1101/gr.244293.118 · Cited by 84
TIM, a targeted insertional mutagenesis method utilizing CRISPR/Cas9 in Chlamydomonas reinhardtii
Picariello, T., Hou, Y., Kubo, T., McNeill, N. A., Yanagisawa, H.-A., Oda, T., & Witman, G. B. (2020) · PLOS ONE · doi:10.1371/journal.pone.0232594 · Cited by 83
“The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system has greatly facilitated our ability to edit genomes in many organisms [12, 13].”
BackgroundCRISPR-mediated genome editing and human diseases
Cai, L., Fisher, A. L., Huang, H., & Xie, Z. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2016.07.003 · Cited by 83
“The CRISPR sequences were eventually found to act as an adaptive bacteria immune defense that destroyed viral pathogens by cutting the DNA of the invader with Cas nucleases.(5,6) Importantly, the Cas nucleases were made pathogen-specific by a unique property of the enzyme, which is the requirement for an RNA guide seq…”
BackgroundLopes, R., & Prasad, M. K. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1339189 · Cited by 82
Snipping around for food: economic, ethical and policy implications of CRISPR/Cas genome editing
Bartkowski, B., Theesfeld, I., Pirscher, F., & Timaeus, J. (2018) · Geoforum · doi:10.1016/j.geoforum.2018.07.017 · Cited by 81
Kumar, N., Stanford, W., de Solis, C., Aradhana, Abraham, N. D., Dao, T.-M. J., Thaseen, S., Sairavi, A., Gonzalez, C. U., & Ploski, J. E. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00413 · Cited by 79
DNA Methylation and Its Implications and Accessibility for Neuropsychiatric Therapeutics
Day, J. J., Kennedy, A. J., & Sweatt, J. D. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124527 · Cited by 78
Newer Gene Editing Technologies toward HIV Gene Therapy
Manjunath, N., Yi, G., Dang, Y., & Shankar, P. (2013) · Viruses · doi:10.3390/v5112748 · Cited by 77
“as a single RNA chimera (called guide or gRNA) that leads to sequence-specific dsDNA cleavage by Cas9 [86].”
BackgroundGenetic Variation and Unintended Risk in the Context of Old and New Breeding Techniques
Singer, S. D., Laurie, J. D., Bilichak, A., Kumar, S., & Singh, J. (2021) · Critical Reviews in Plant Sciences · doi:10.1080/07352689.2021.1883826 · Cited by 77
“In the case of systems based on Cas9 from Streptomyces pyogenes, which is currently the most widely used Cas protein for genome editing in plants, the PAM sequence consists of 50-NGG-30 (Jinek et al., 2012) and less frequently ‘NAG’ (Meng et al.”
BackgroundMethodInfluentialGenome editing and improvement of abiotic stress tolerance in crop plants
Yadav, R. K., Tripathi, M. K., Tiwari, S., Tripathi, N., Asati, R., Chauhan, S., Tiwari, P. N., & Payasi, D. K. (2023) · Life · doi:10.3390/life13071456 · Cited by 75
Vlčko, T., & Ohnoutková, L. (2020) · Plants · doi:10.3390/plants9020195 · Cited by 74
“In the present study, genome-edited barley plants were developed using the CRISPR/Cas9 system [37] adapted and optimized for use in monocot plants [41] in order to prepare barley lpa mutants.”
BackgroundMethodEngineering virus resistance via CRISPR–Cas systems
Mahas, A., & Mahfouz, M. (2018) · Current Opinion in Virology · doi:10.1016/j.coviro.2018.06.002 · Cited by 74
Highly efficient and genotype-independent barley gene editing based on anther culture
Han, Y., Broughton, S., Liu, L., Zhang, X.-Q., Zeng, J., He, X., & Li, C. (2021) · Plant Communications · doi:10.1016/j.xplc.2020.100082 · Cited by 73
“It has been well documented that Cas9 induces DNA double-strand breaks (DSBs) and that the DSBs are repaired by the error-prone non-homologous endjoining pathway, which typically introduces 1- to 4-bp indels due to the annealing of single strands with short regions of microhomology (Lieber, 2010; Jinek et al., 2012; H…”
BackgroundUsing transgenic reporter assays to functionally characterize enhancers in animals
Kvon, E. Z. (2015) · Genomics · doi:10.1016/j.ygeno.2015.06.007 · Cited by 73
“Recently developed CRISPR/Cas9 system allows to introduce double stranded breaks at any desired location of the genome, and it appears to be highly ef fi cient in a wide range of organisms [97,98].”
BackgroundGene editing for plant resistance to abiotic factors: a systematic review
Nascimento, F. D. S., Rocha, A. D. J., Soares, J. M. D. S., Mascarenhas, M. S., Ferreira, M. D. S., Morais Lino, L. S., Ramos, A. P. D. S., Diniz, L. E. C., Mendes, T. A. D. O., Ferreira, C. F., et al. (2023) · Plants · doi:10.3390/plants12020305 · Cited by 71
Genetic and epigenetic control of gene expression by CRISPR–Cas systems
Lo, A., & Qi, L. (2017) · F1000Research · doi:10.12688/f1000research.11113.1 · Cited by 72
“To simplify the use of the CRISPR–Cas9 systems for genome-engineering applications, a seminal study demonstrated that crRNA and tracrRNA could be engineered into a chimeric single guide RNA (sgRNA), which is easily programmable and portable (Figure 1A) 6 .”
MethodSingle and multiple gene knockouts by CRISPR–Cas9 in maize
Doll, N. M., Gilles, L. M., Gérentes, M.-F., Richard, C., Just, J., Fierlej, Y., Borrelli, V. M. G., Gendrot, G., Ingram, G. C., Rogowsky, P. M., et al. (2019) · Plant Cell Reports · doi:10.1007/s00299-019-02378-1 · Cited by 71
Holme, I. B., Wendt, T., Gil-Humanes, J., Deleuran, L. C., Starker, C. G., Voytas, D. F., & Brinch-Pedersen, H. (2017) · Plant Molecular Biology · doi:10.1007/s11103-017-0640-6 · Cited by 71
“Presently, nucleases that can be designed to cleave at specific sites in a genome include meganucleases, zinc finger nucleases, transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPR/Cas9) (Bibikova et al. 2003; Bogdanove and Voytas 2011; Epinat e…”
BackgroundCRISPR mediated somatic cell genome engineering in the chicken
Véron, N., Qu, Z., Kipen, P. A. S., Hirst, C. E., & Marcelle, C. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.08.007 · Cited by 71
CRISPR-based genome editing in wheat: a comprehensive review and future prospects
Kumar, R., Kaur, A., Pandey, A., Mamrutha, H. M., & Singh, G. P. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04761-3 · Cited by 70
Current Bioinformatics Tools to Optimize CRISPR/Cas9 Experiments to Reduce Off-Target Effects
Naeem, M., & Alkhnbashi, O. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076261 · Cited by 70
“Later on, Jennifer Doudna and Emmanuelle Charpentier (Nobel laureate 2020) modulated CRISPR-array-generated RNA (gRNA) to target the desired genomic sites in prokaryotic and eukaryotic cells to specifically edit their genomes, and this whole mechanism led to the development of the CRISPR/cas9 system as a precise RNA-g…”
BackgroundTowards a new era in medicine: therapeutic genome editing
Porteus, M. H. (2015) · Genome Biology · doi:10.1186/s13059-015-0859-y · Cited by 69
“In the past 5 years, however, the development of TAL effector nucleases (TALENs) [35–37], CRISPR/Cas9 nucleases [38–40], and hybrid nuclease platforms [41–43] have dramatically expanded the engineered nuclease toolbox.”
BackgroundGenetic engineering in organoids
Teriyapirom, I., Batista-Rocha, A. S., & Koo, B.-K. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-020-02029-z · Cited by 68
Tools and targets: the dual role of plant viruses in CRISPR–Cas genome editing
Uranga, M., & Daròs, J. (2023) · The Plant Genome · doi:10.1002/tpg2.20220 · Cited by 68
“…a 5′-TTTV-3′ PAM in the target DNA, the 23-bp protospacer of the crRNA (yellow) base-pairs with its complementary DNA site, and the endonucleolytic cleavage generates a PAM-distal DSB with 5′ overhangs vitro and in eukaryotic cells (Barrangou et al., 2007; Jinek et al., 2012; Mali et al., 2013).”
BackgroundGenome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies
McTague, A., Rossignoli, G., Ferrini, A., Barral, S., & Kurian, M. A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.630600 · Cited by 67
Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology
Zhang, D., Li, Z., & Li, J.-F. (2016) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2016.03.001 · Cited by 67
“M AN US CR IP T AC CE PT ED Name Origin Primary PAM Activity in planta Reference SpCas9 Streptococcus pyogenes NGG (3’ to protospacer) 1 Yes Jinek et al., 2012 SpCas9VQR Engineered NGAG (3’ to protospacer) Unevaluated Kleinstiver et al., 2015 SpCas9VRER Engineered NGCG (3’ to protospacer)…”
BackgroundInfluentialOne-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids
Geurts, M. H., Gandhi, S., Boretto, M. G., Akkerman, N., Derks, L. L. M., van Son, G., Celotti, M., Harshuk-Shabso, S., Peci, F., Begthel, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40701-3 · Cited by 66
“Upon target recognition, the DNA strands are opened in an R-loop and individually cleaved, which results in a double-strand break (DSB) 22,23 Subsequent repair of the DSB by non-homologous end joining (NHEJ) mechanism can result in knock-out of the gene upon gain or loss of base pairs at the break…”
InfluentialThe iCRISPR Platform for Rapid Genome Editing in Human Pluripotent Stem Cells
Zhu, Z., González, F., & Huangfu, D. (2014) · Methods in Enzymology · doi:10.1016/b978-0-12-801185-0.00011-8 · Cited by 66
“CRISPR/Cas-mediated genome engineering requires two components: the constant RNA-guided DNA endonuclease Cas9 protein required for DNA cleavage, and a variable CRISPR RNA (crRNA) and trans-activating crRNA (tracrRNA) duplex that specifies DNA target recognition (Jinek et al., 2012).”
BackgroundMethodAntiviral signalling by a cyclic nucleotide activated CRISPR protease
Rouillon, C., Schneberger, N., Chi, H., Blumenstock, K., Da Vela, S., Ackermann, K., Moecking, J., Peter, M. F., Boenigk, W., Seifert, R., et al. (2023) · Nature · doi:10.1038/s41586-022-05571-7 · Cited by 66
Emerging Species and Genome Editing Tools: Future Prospects in Cyanobacterial Synthetic Biology
Gale, G. A. R., Schiavon Osorio, A. A., Mills, L. A., Wang, B., Lea-Smith, D. J., & McCormick, A. J. (2019) · Microorganisms · doi:10.3390/microorganisms7100409 · Cited by 61
Lineage tracing using a Cas9-deaminase barcoding system targeting endogenous L1 elements
Hwang, B., Lee, W., Yum, S.-Y., Jeon, Y., Cho, N., Jang, G., & Bang, D. (2019) · Nature Communications · doi:10.1038/s41467-019-09203-z · Cited by 65
Glaser, V., Flugel, C., Kath, J., Du, W., Drosdek, V., Franke, C., Stein, M., Pruß, A., Schmueck-Henneresse, M., Volk, H.-D., et al. (2023) · Genome biology · doi:10.1186/s13059-023-02928-7 · Cited by 65
“Programmable nucleases, such as zinc finger nucleases [4], TALE nucleases [5], or CRISPR-Cas [6, 7], enable the induction of DNA double-strand breaks (DSBs) at precise locations in the genome.”
Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy
Fortunato, F., Rossi, R., Falzarano, M. S., & Ferlini, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040820 · Cited by 64
“The programmable nucleases comprise meganucleases [87], zinc-finger nucleases [88], transcription activator-like effector nucleases [89], and the CRISPR/Cas9 system [90].”
BackgroundCas9-directed immune tolerance in humans—a model to evaluate regulatory T cells in gene therapy?
Wagner, D. L., Peter, L., & Schmueck-Henneresse, M. (2021) · Gene Therapy · doi:10.1038/s41434-021-00232-2 · Cited by 63
Characterization and Repurposing of Type I and Type II CRISPR–Cas Systems in Bacteria
Hidalgo-Cantabrana, C., Goh, Y. J., & Barrangou, R. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.09.013 · Cited by 63
Lin, S.-C., Haga, K., Zeng, X.-L., & Estes, M. K. (2022) · Nature Protocols · doi:10.1038/s41596-021-00669-0 · Cited by 63
Efficient genomic correction methods in human iPS cells using CRISPR–Cas9 system
Li, H. L., Gee, P., Ishida, K., & Hotta, A. (2016) · Methods · doi:10.1016/j.ymeth.2015.10.015 · Cited by 62
Customizing the genome as therapy for the β-hemoglobinopathies.
Canver, M. C., & Orkin, S. H. (2016) · Blood · doi:10.1182/blood-2016-01-678128 · Cited by 61
Targeted Transcriptional Repression in Bacteria Using CRISPR Interference (CRISPRi)
Hawkins, J. S., Wong, S., Peters, J. M., Almeida, R., & Qi, L. S. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2687-9_23 · Cited by 61
“have shown that a designed chimeric single-guide (sg) RNA derived from Streptococcus pyogenes could solely direct the DNA targeting and cleavage activities of Cas9 [ 5 ].”
CRISPR system: Discovery, development and off-target detection
Chen, S., Yao, Y., Zhang, Y., & Fan, G. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109577 · Cited by 60
PAM-flexible genome editing with an engineered chimeric Cas9
Zhao, L., Koseki, S. R. T., Silverstein, R. A., Amrani, N., Peng, C., Kramme, C., Savic, N., Pacesa, M., Rodríguez, T. C., Stan, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41829-y · Cited by 59
Chennakesavulu, K., Singh, H., Trivedi, P. K., Jain, M., & Yadav, S. R. (2022) · Plant Cell Reports · doi:10.1007/s00299-021-02681-w · Cited by 60
CRISPR/Cas systems: opportunities and challenges for crop breeding
Biswas, S., Zhang, D., & Shi, J. (2021) · Plant Cell Reports · doi:10.1007/s00299-021-02708-2 · Cited by 58
“Notably, there is no strict requirement for PAM sequence for some Cas13 orthologues (Wolter and Puchta 2018).”
BackgroundInfluentialGeneration of targeted mouse mutants by embryo microinjection of TALEN mRNA
Wefers, B., Panda, S. K., Ortiz, O., Brandl, C., Hensler, S., Hansen, J., Wurst, W., & Kühn, R. (2013) · Nature Protocols · doi:10.1038/nprot.2013.142 · Cited by 58
Advances in Genome Editing and Application to the Generation of Genetically Modified Rat Models
Chenouard, V., Remy, S., Tesson, L., Ménoret, S., Ouisse, L.-H., Cherifi, Y., & Anegon, I. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.615491 · Cited by 57
VvEPFL9-1 knock-out via CRISPR/Cas9 reduces stomatal density in grapevine
Clemens, M., Faralli, M., Lagreze, J., Bontempo, L., Piazza, S., Varotto, C., Malnoy, M., Oechel, W., Rizzoli, A., & Dalla Costa, L. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.878001 · Cited by 57
“Gene editing via the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) (Jinek et al., 2012) is to date the most powerful tool for functional genomics studies in plants (Liu et al.”
MethodWu, Y., Ren, Q., Zhong, Z., Liu, G., Han, Y., Bao, Y., Liu, L., Xiang, S., Liu, S., Tang, X., et al. (2022) · Plant Biotechnology Journal · doi:10.1111/pbi.13838 · Cited by 56
“Streptococcus pyogenes Cas9 (SpCas9) is the predominant Cas9 widely used, 50 partly due to its high genome editing efficiency and simple NGG protospacer adjacent 51 motif (PAM) requirement[1-3].”
BackgroundBannister, S., Antonova, O., Polo, A., Lohs, C., Hallay, N., Valinciute, A., Raible, F., & Tessmar-Raible, K. (2014) · Genetics · doi:10.1534/genetics.113.161091 · Cited by 56
“Cas9/CRISPR technology involves the use of short guide RNAs (sgRNAs) that direct a bacterially derived endonuclease (Cas9) to recognize specific sites in the genome and induce DNA double-strand breaks (Jinek et al. 2012).”
BackgroundResponses of innate immune cells to group A Streptococcus.
Fieber, C., & Kovarik, P. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00140 · Cited by 56
“…peptide; NET, neutrophil extracellular trap; SIC, streptococcal inhibitor of complement; SLO, streptolysin O; SLS, streptolysin S. first described using GAS as a CRISPR model (Jinek et al., 2012), should facilitate the development of new cell culture models, particularly in the human system.”
BackgroundSelective targeting of KRAS oncogenic alleles by CRISPR/Cas9 inhibits proliferation of cancer cells
Lee, W., Lee, J. H., Jun, S., Lee, J. H., & Bang, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-30205-2 · Cited by 53
Genetic medicines for CF: Hype versus reality
Alton, E. W. F. W., Boyd, A. C., Davies, J. C., Gill, D. R., Griesenbach, U., Harrison, P. T., Henig, N., Higgins, T., Hyde, S. C., Innes, J. A., et al. (2016) · Pediatric Pulmonology · doi:10.1002/ppul.23543 · Cited by 53
“A radically different way to create a DSB and edit cells is the RNA-guided DNA-specific nuclease CRISPR/Cas9 editing system 55 , which was used to demonstrate that correction of the F508del mutation resulted in restoration of CFTR function in human gut stem cells 56 .”
Raas, Q., Gondcaille, C., Hamon, Y., Leoni, V., Caccia, C., Ménétrier, F., Lizard, G., Trompier, D., & Savary, S. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.02.006 · Cited by 53
A role for Rab11 in the homeostasis of the endosome-lysosomal pathway
Zulkefli, K. L., Houghton, F. J., Gosavi, P., & Gleeson, P. A. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.04.010 · Cited by 52
Recent Progress and Challenges in CRISPR-Cas9 Engineered Algae and Cyanobacteria
Patel, V. K., Das, A., Kumari, R., & Kajla, S. (2023) · Algal Research · doi:10.1016/j.algal.2023.103068 · Cited by 50
Vamsi Krishna, K., Bharathi, N., George Shiju, S., Alagesan Paari, K., & Malaviya, A. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-20637-9 · Cited by 51
“A thorough transcriptional analysis of C. acetobutylicum produced in batch cultures using a DNA microarray technology showed key aspects of the genetic processes related to Clostridial development in 2008 (Jones et al.”
BackgroundInfluentialRNA-targeting strategies as a platform for ocular gene therapy
Kumar, S., Fry, L. E., Wang, J.-H., Martin, K. R., Hewitt, A. W., Chen, F. K., & Liu, G.-S. (2023) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101110 · Cited by 51
The double life of CRISPR–Cas13
Bot, J. F., van der Oost, J., & Geijsen, N. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102789 · Cited by 50
CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges
Demirci, S., Leonard, A., Haro-Mora, J. J., Uchida, N., & Tisdale, J. F. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2018_331 · Cited by 50
Therapy Approaches for Stargardt Disease
Piotter, E., McClements, M. E., & MacLaren, R. E. (2021) · Biomolecules · doi:10.3390/biom11081179 · Cited by 49
Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells
Voets, O., Tielen, F., Elstak, E., Benschop, J., Grimbergen, M., Stallen, J., Janssen, R., van Marle, A., & Essrich, C. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182974 · Cited by 48
“Guide RNA sequences were adapted from Jinek et al. 2012 [8].”
MethodIntegrated approaches for increasing plant yield under salt stress
Ahmad, I., Zhu, G., Zhou, G., Younas, M. U., Suliman, M. S. E., Liu, J., Zhu, Y. M., & Salih, E. G. I. (2023) · Frontiers in Plant Science · doi:10.3389/fpls.2023.1215343 · Cited by 48
“Due to this obstacle, the tools of TALENs and ZFNs in plants have been limited (Jinek et al., 2012).”
BackgroundMethodAmann, T., Schmieder, V., Faustrup Kildegaard, H., Borth, N., & Andersen, M. R. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27101 · Cited by 46
“A cc ep te d A rt ic le mAb, rhGMCSF P. pastoris OE (STT3D) Macroheterogeneity ↓ (Choi et al., 2012) GC N. benthamiana RNAi (GNTI) Immunogenic plant sugar residues ↓ (Limkul et al., 2016) mAb L. minor7 siRNA KD (XYLT/FUT) Immunogenic plant sugar residues ↓ (Cox et al., 2006) mAb N. tabacum CRISPR/Cas9 KO (XYLT/FUT) Im…”
InfluentialKulcsár, P. I., Tálas, A., Tóth, E., Nyeste, A., Ligeti, Z., Welker, Z., & Welker, E. (2020) · Nature Communications · doi:10.1038/s41467-020-15021-5 · Cited by 45
Tariq, A., Mushtaq, M., Yaqoob, H., Bhat, B. A., Zargar, S. M., Raza, A., Ali, S., Charagh, S., Mubarik, M. S., Zaman, Q. U., et al. (2023) · GM Crops & Food · doi:10.1080/21645698.2023.2219111 · Cited by 45
G-quadruplex-based CRISPR photoswitch for spatiotemporal control of genomic modulation
Deng, H., Xu, H., Wang, Y., Jia, R., Ma, X., Feng, Y., & Chen, H. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad178 · Cited by 45
The Vibrio cholerae Seventh Pandemic Islands act in tandem to defend against a circulating phage
O’Hara, B. J., Alam, M., & Ng, W.-L. (2022) · PLOS Genetics · doi:10.1371/journal.pgen.1010250 · Cited by 45
Emerging applications of gene editing technologies for the development of climate-resilient crops
Chavhan, R. L., Jaybhaye, S. G., Hinge, V. R., Deshmukh, A. S., Shaikh, U. S., Jadhav, P. K., Kadam, U. S., & Hong, J. C. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1524767 · Cited by 55
Umeyama, T., Hayashi, Y., Shimosaka, H., Inukai, T., Yamagoe, S., Takatsuka, S., Hoshino, Y., Nagi, M., Nakamura, S., Kamei, K., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00894-18 · Cited by 43
“By forming a ribonucleoprotein complex with an artificial single guide RNA (sgRNA) designed to target a cellular gene, the Cas9 nuclease efficiently introduces double-stranded breaks (DSBs) at the corresponding target locus (6).”
BackgroundSchleidgen, S., Dederer, H.-G., Sgodda, S., Cravcisin, S., Lüneburg, L., Cantz, T., & Heinemann, T. (2020) · BMC Medical Ethics · doi:10.1186/s12910-020-00487-1 · Cited by 43
Deep mutational scanning of essential bacterial proteins can guide antibiotic development
Dewachter, L., Brooks, A. N., Noon, K., Cialek, C., Clark-ElSayed, A., Schalck, T., Krishnamurthy, N., Versées, W., Vranken, W., & Michiels, J. (2023) · Nature Communications · doi:10.1038/s41467-023-35940-3 · Cited by 43
Massively targeted evaluation of therapeutic CRISPR off-targets in cells
Pan, X., Qu, K., Yuan, H., Xiang, X., Anthon, C., Pashkova, L., Liang, X., Han, P., Corsi, G. I., Xu, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31543-6 · Cited by 42
“It has been well characterized that the CRISPR is less tolerated to mismatches in the PAM-proximal 10 – 12 nucleotides 49 – 51 .”
BackgroundGenome-editing strategies for treating human retinal degenerations
Quinn, J., Musa, A., Kantor, A., McClements, M. E., Cehajic-Kapetanovic, J., MacLaren, R. E., & Xue, K. (2021) · Human Gene Therapy · doi:10.1089/hum.2020.231 · Cited by 41
“If the DNA sequence matches the sgRNA target sequence, the HNH and RuvC catalytic domains of the endonuclease cleave both strands of the target DNA, generating a doublestrand break (DSB).(12)”
BackgroundPrecise and broad scope genome editing based on high-specificity Cas9 nickases
Wang, Q., Liu, J., Janssen, J. M., Le Bouteiller, M., Frock, R. L., & Gonçalves, M. A. F. V. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1236 · Cited by 41
“The PAM of the prototypic Streptococcus pyogenes Cas9 (SpCas9) nuclease and that of its orthologue Staphylococcus aureus Cas9 (SaCas9) nuclease, reads NGG and NNGRRT, respectively (3,4).”
BackgroundSapp, V., Aguirre, A., Mainkar, G., Ding, J., Adler, E., Liao, R., Sharma, S., & Jain, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-92988-1 · Cited by 40
Performance of the Cas9 Nickase System in Drosophila melanogaster
Ren, X., Yang, Z., Mao, D., Chang, Z., Qiao, H.-H., Wang, X., Sun, J., Hu, Q., Cui, Y., Liu, L.-P., et al. (2014) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.114.013821 · Cited by 40
“…melanogaster to generate DSBs in the genome and induce indel mutations through nonhomologous end joining (NHEJ) or sequencespecific mutations through homology-directed repairs (HDRs) for recessive viable genes (Baena-Lopez et al. 2013; Bassett et al. 2013; Gratz et al. 2013; Kondo and Ueda…”
BackgroundMethodInfluentialCRISPR/Cas9-Mediated Phage Resistance Is Not Impeded by the DNA Modifications of Phage T4
Yaung, S. J., Esvelt, K. M., & Church, G. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098811 · Cited by 39
“CRISPR-Cas systems also function as endonucleases, though unlike restriction enzymes, their recognition sites are programmable by CRISPR RNAs (crRNAs) [3].”
BackgroundSOX9 maintains human foetal lung tip progenitor state by enhancing WNT and RTK signalling
Sun, D., Llora Batlle, O., van den Ameele, J., Thomas, J. C., He, P., Lim, K., Tang, W., Xu, C., Meyer, K. B., Teichmann, S. A., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2022111338 · Cited by 38
“CRISPR genetic perturbation tools have transformed biology research (Jinek et al , 2012; Cho et al , 2013; Cong et al , 2013; Mali et al , 2013).”
Shen, Q., Ruan, H., Zhang, H., Wu, T., Zhu, K., Han, W., Dong, R., Ming, T., Qi, H., & Zhang, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1375120 · Cited by 38
“…the CRISPR-Cas system, which is constructed from clustered regularly spaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas) (Jinek et al., 2012) have been widely used, among which the CRISPR-Cas system, considered the third-generation genome editing tool, earns a dominant…”
Cellular cartography: Towards an atlas of the neuronal microtubule cytoskeleton
Iwanski, M. K., & Kapitein, L. C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1052245 · Cited by 38
“To this end, CRISPR-based approaches (Jinek et al., 2012; Doudna and Charpentier, 2014; Willems et al., 2020; Droogers et al., 2022) will be important to determine the endogenous distribution of MAPs and tubulin isotypes, but this cannot be used to visualize PTMs or whether microtubules are in an expanded or compacted…”
Background
Metadata
- Authors
- Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (HHMI), University of California, Berkeley, CA 94720, USA.
- University of Vienna (AT)
- Umeå Centre for Microbial Research (SE)
- University of California, Berkeley (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Chylinski, Krzysztof
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2012-08-17
- Volume
- 337
- Issue
- 6096
- Pages
- 816-821
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6286148
- OpenAlex
- W2045435533
- Semantic Scholar
- 68d962effe5520777791bd6ec8ffa4b963ba4f38
- Cited by
- 17,116
- References
- 48
- Citations by year
- 2026: 1083 · 2025: 1512 · 2024: 1602 · 2023: 1572 · 2022: 1795 · 2021: 1793 · 2020: 1577 · 2019: 1344 · 2018: 1255 · 2017: 1141 · 2016: 1018 · 2015: 680 · 2014: 467 · 2013: 231 · 2012: 29
- FWCI
- 180.75
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, sequence-specific DNA cleavage, DNA double-strand breaks
- MeSH terms
- Bacteriophages, Base Sequence, Molecular Sequence Data, Nucleic Acid Conformation, Plasmids, RNA, Streptococcus pyogenes, Deoxyribonucleases, Type II Site-Specific, DNA Cleavage, DNA Breaks, Double-Stranded, Inverted Repeat Sequences
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.